(ELIS) Elis - Overview

Sector: Industrials | Industry: Specialty Business Services | Exchange: PA (France) | Market Cap: 5.899m EUR | Total Return: 14.3% in 12m

Workwear, Linens, Hygiene Services, Pest Control, Waste Management
Total Rating 56
Safety 72
Buy Signal 0.19
Specialty Business Services
Industry Rotation: +0.6
Market Cap: 6.85B
Avg Turnover: 9.22M
Risk 3d forecast
Volatility23.4%
VaR 5th Pctl3.78%
VaR vs Median-1.95%
Reward TTM
Sharpe Ratio0.64
Rel. Str. IBD47.4
Rel. Str. Peer Group52.5
Character TTM
Beta0.184
Beta Downside-0.313
Hurst Exponent0.524
Drawdowns 3y
Max DD21.94%
CAGR/Max DD0.83
CAGR/Mean DD2.52

Warnings

Choppy

Tailwinds

No distinct edge detected

Description: ELIS Elis

Elis SA is a France-based provider of circular services specializing in flat linen, workwear, and hygiene solutions across Europe and Latin America. The company operates a rental-maintenance model, which reduces capital expenditure for clients by outsourcing the laundering and upkeep of essential textiles and equipment. Its portfolio includes personal protective equipment, cleanroom garments, washroom hygiene, and pest control services.

The business serves diverse end-markets including healthcare, hospitality, and heavy industry, benefiting from recurring revenue through long-term service contracts. In the diversified support services sector, high operational efficiency in logistics and industrial laundering is a primary barrier to entry. For a deeper look into the companys valuation metrics, consider reviewing the latest data on ValueRay.

Founded in 1883, Elis maintains a significant geographic footprint with a focus on hygiene and environmental services. The company also manages specialized waste disposal for the healthcare sector and provides floor protection and beverage solutions to commercial clients.

Headlines to Watch Out For
  • Outsourcing trends in European hospitality and healthcare drive organic revenue growth
  • Rising energy and labor costs pressure operating margins in textile services
  • Strategic acquisitions in Latin America expand market share and geographic diversification
  • High leverage ratios and interest rate sensitivity impact free cash flow valuation
  • Demand for reusable cleanroom and workwear solutions boosts high-margin service contracts
Piotroski VR-10 (Strict) 7.5
Net Income: 704.4m TTM > 0 and > 6% of Revenue
FCF/TA: 0.12 > 0.02 and ΔFCF/TA 5.29 > 1.0
NWC/Revenue: -4.25% < 20% (prev -5.10%; Δ 0.85% < -1%)
CFO/TA 0.30 > 3% & CFO 2.86b > Net Income 704.4m
Net Debt (4.72b) to EBITDA (3.11b): 1.52 < 3
Current Ratio: 0.81 > 1.5 & < 3
Outstanding Shares: last quarter (253.3m) vs 12m ago -10.71% < -2%
Gross Margin: 43.08% > 18% (prev 0.43%; Δ 4.27k% > 0.5%)
Asset Turnover: 99.29% > 50% (prev 78.49%; Δ 20.80% > 0%)
Interest Coverage Ratio: 5.71 > 6 (EBITDA TTM 3.11b / Interest Expense TTM 223.9m)
Altman Z'' 1.51
A: -0.04 (Total Current Assets 1.65b - Total Current Liabilities 2.05b) / Total Assets 9.57b
B: 0.17 (Retained Earnings 1.59b / Total Assets 9.57b)
C: 0.14 (EBIT TTM 1.28b / Avg Total Assets 9.44b)
D: 0.32 (Book Value of Equity 1.82b / Total Liabilities 5.76b)
Altman-Z'' = 1.51 = BB
Beneish M -3.17
DSRI: 0.89 (Receivables 1.02b/899.8m, Revenue 9.37b/7.30b)
GMI: 1.00 (GM 43.08% / 43.17%)
AQI: 0.96 (AQ_t 0.49 / AQ_t-1 0.52)
SGI: 1.28 (Revenue 9.37b / 7.30b)
TATA: -0.22 (NI 704.4m - CFO 2.86b) / TA 9.57b)
Beneish M = -3.17 (Cap -4..+1) = AA
What is the price of ELIS shares?

As of May 30, 2026, the stock is trading at EUR 27.12 with a total of 833,881 shares traded.
Over the past week, the price has changed by +1.03%, over one month by +5.72%, over three months by +0.66% and over the past year by +14.30%.

Is ELIS a buy, sell or hold?

Elis has no consensus analysts rating.

Elis (ELIS) - Fundamental Data Overview as of 30 May 2026
Market Cap USD = 6.85b (5.90b EUR * 1.1615 EUR.USD)
P/E Trailing = 18.2877
P/E Forward = 13.3511
P/S = 1.2298
P/B = 1.5508
Revenue TTM = 9.37b EUR
EBIT TTM = 1.28b EUR
EBITDA TTM = 3.11b EUR
Long Term Debt = 2.62b EUR (from longTermDebt, last quarter)
Short Term Debt = 940.5m EUR (from shortTermDebt, last quarter)
Debt = 4.82b EUR (from shortLongTermDebtTotal, last quarter) + Leases 703.2m
Net Debt = 4.72b EUR (calculated: Debt 4.82b - CCE 101.8m)
Enterprise Value = 10.6b EUR (5.90b + Debt 4.82b - CCE 101.8m)
Interest Coverage Ratio = 5.71 (Ebit TTM 1.28b / Interest Expense TTM 223.9m)
EV/FCF = 9.39x (Enterprise Value 10.6b / FCF TTM 1.13b)
FCF Yield = 10.65% (FCF TTM 1.13b / Enterprise Value 10.6b)
FCF Margin = 12.07% (FCF TTM 1.13b / Revenue TTM 9.37b)
Net Margin = 7.52% (Net Income TTM 704.4m / Revenue TTM 9.37b)
Gross Margin = 43.08% ((Revenue TTM 9.37b - Cost of Revenue TTM 5.33b) / Revenue TTM)
Gross Margin QoQ = 47.57% (prev 45.74%)
Tobins Q-Ratio = 1.11 (Enterprise Value 10.6b / Total Assets 9.57b)
Interest Expense / Debt = 4.64% (Interest Expense 223.9m / Debt 4.82b)
Taxrate = 22.76% (63.1m / 277.3m)
NOPAT = 987.4m (EBIT 1.28b * (1 - 22.76%))
Current Ratio = 0.81 (Total Current Assets 1.65b / Total Current Liabilities 2.05b)
Debt / Equity = 1.27 (Debt 4.82b / totalStockholderEquity, last quarter 3.81b)
Debt / EBITDA = 1.52 (Net Debt 4.72b / EBITDA 3.11b)
Debt / FCF = 4.18 (Net Debt 4.72b / FCF TTM 1.13b)
Total Stockholder Equity = 3.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.46% (Net Income 704.4m / Total Assets 9.57b)
RoE = 19.55% (Net Income TTM 704.4m / Total Stockholder Equity 3.60b)
RoCE = 20.55% (EBIT 1.28b / Capital Employed (Equity 3.60b + L.T.Debt 2.62b))
RoIC = 11.81% (NOPAT 987.4m / Invested Capital 8.36b)
WACC = 5.26% (E(5.90b)/V(10.7b) * Re(6.63%) + D(4.82b)/V(10.7b) * Rd(4.64%) * (1-Tc(0.23)))
Discount Rate = 6.63% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 26.97 | Cagr: 1.91%
[DCF] Terminal Value 77.97% ; FCFF base≈921.6m ; Y1≈1.06b ; Y5≈1.55b
[DCF] Fair Price = 84.53 (EV 23.4b - Net Debt 4.72b = Equity 18.7b / Shares 220.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 50.73 | EPS CAGR: 31.65% | SUE: 0.0 | # QB: 0
Revenue Correlation: 99.32 | Revenue CAGR: 5.92% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=2.02 | Chg30d=+0.52% | Revisions=+0% | GrowthEPS=+9.3% | GrowthRev=+4.9%
EPS next Year (2027-12-31): EPS=2.19 | Chg30d=+0.52% | Revisions=+17% | GrowthEPS=+8.0% | GrowthRev=+3.9%
[Analyst] Revisions Ratio: +17%